Peer-reviewedCC BY-NC-NDEClinicalMedicine
Immunogenicity and safety of an interchangeable vaccination schedule of two inactivated Japanese encephalitis vaccines: a multicentric, phase IV, open-label, randomized controlled trial
10 affiliations
- 1Indian Council of Medical Research National Institute of Epidemiology, Chennai, India
- 2Indian Council of Medical Research - National Institute of Virology, Pune, India
- 3Mahatma Gandhi Institute of Medical Sciences, Sewagram, Wardha, India
- 4All India Institute of Medical Sciences, Bhubaneswar, India
- 5Indian Council of Medical Research - National Institute for Research in Bacterial Infections, Kolkata, India
- 6All India Institute of Medical Sciences, Bibinagar, India
- 7All India Institute of Medical Sciences, Patna, India
- 8Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India
- 9BC Roy Post Graduate Institute of Paediatric Sciences, Kolkata, India
- 10Indian Council of Medical Research, New Delhi, India
Related
- Comparative immunogenicity of several inactivated influenza vaccines among healthcare workers in Hong Kong
- Immunogenicity and Protective Efficacy of a Trivalent Whole-Virion Inactivated SARS-CoV-2 Vaccine Against Vaccine-Matched Ancestral, Delta, and Omicron BA.5 Variants in K18-hACE2 Mice.
- Immunogenicity and safety of trivalent inactivated influenza vaccine in adults living with HIV compared with HIV-uninfected adults: a study from China
- Immunogenicity of sequential conjugate and non-conjugate pneumococcal vaccination in dialysis patients and kidney transplant recipients: a 12-month serological follow-up
- Safety and immunogenicity of a first-generation modified vaccinia virus Ankara-vectored SARS-CoV-2 vaccine candidate with mRNA-based booster vaccination: A phase 1 trial.
BibTeX
@article{thangaraj2026immunogenicity,
title = {{Immunogenicity and safety of an interchangeable vaccination schedule of two inactivated Japanese encephalitis vaccines: a multicentric, phase IV, open-label, randomized controlled trial}},
author = {Jeromie Wesley Vivian Thangaraj and Himabindu Reddy and Gajanan N. Sapkal and Saravana Kumar Velusamy and Manish A. Jain and Bhagirathi Dwibedi and Suman Kanungo and Rashmi Kundapur and Sanjay Pandey and Gururaj Rao Deshpande and Ala Saritha and Vishnunath Kadavath and Kaliaperumal Kanagasabai and Chetna Maliye and Swayam Pragyan Parida and Agniva Majumdar and Mounika Reddy and Chandramani Singh and Archana R. Lade and Sandip Samanta and Arvind Kumar Singh and Sunil Kumar Chawan and Binod Kumar Pati and Rashi Srivastava and Sanjay Kumar Panda and Jayanta Saha and Bhushan Kamble and Asha Salunke and Pardeep Kumar and Sabarinathan Ramasamy and Mugunthan Narayanan Muthulakhsmi and Vijay P. Bondre and Leyanna Susan George and Nivedita Gupta and Jeyashree Kathiresan and Manoj V. Murhekar},
journal = {EClinicalMedicine},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13675861},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Immunogenicity and safety of an interchangeable vaccination schedule of two inactivated Japanese encephalitis vaccines: a multicentric, phase IV, open-label, randomized controlled trial
AU - Jeromie Wesley Vivian Thangaraj
AU - Himabindu Reddy
AU - Gajanan N. Sapkal
AU - Saravana Kumar Velusamy
AU - Manish A. Jain
AU - Bhagirathi Dwibedi
AU - Suman Kanungo
AU - Rashmi Kundapur
AU - Sanjay Pandey
AU - Gururaj Rao Deshpande
AU - Ala Saritha
AU - Vishnunath Kadavath
AU - Kaliaperumal Kanagasabai
AU - Chetna Maliye
AU - Swayam Pragyan Parida
AU - Agniva Majumdar
AU - Mounika Reddy
AU - Chandramani Singh
AU - Archana R. Lade
AU - Sandip Samanta
AU - Arvind Kumar Singh
AU - Sunil Kumar Chawan
AU - Binod Kumar Pati
AU - Rashi Srivastava
AU - Sanjay Kumar Panda
AU - Jayanta Saha
AU - Bhushan Kamble
AU - Asha Salunke
AU - Pardeep Kumar
AU - Sabarinathan Ramasamy
AU - Mugunthan Narayanan Muthulakhsmi
AU - Vijay P. Bondre
AU - Leyanna Susan George
AU - Nivedita Gupta
AU - Jeyashree Kathiresan
AU - Manoj V. Murhekar
PY - 2026
DA - 2026/09/22
JO - EClinicalMedicine
UR - https://europepmc.org/article/PMC/PMC13675861
SN - 2589-5370
ER -